Course Overview

Microplastics in our Waterways and Effects on Health and the Environment

In this presentation, you will learn more detail about microplastics, their origin and use, their geographic distribution, and the effects they may have on human and environmental health.
Write your awesome label here.

2021 Annual Conference

October 29-31, 2021

Required Lessons

1 lesson with video, quiz, and evaluation

Time to Complete

45 minutes

CME Eligible*

.75 credits
Click the buttons below to view detailed information on this course  
Course Info
Course Faculty
Accreditation/CME

What you will learn

 Course Summary

Nearly all of our freshwater and ocean is infiltrated with plastic pollution, and can take hundreds to thousands of years to degrade. As it degrades, it creates what is known as microplastics. Microplastics are defined as particulate or fiber composed of plastic that are smaller than 0.5 millimeter. Microplastics can be introduced directly into waterways and oceans, and can be mistaken for food by aquatic animals, or inadvertently ingested. This presentation will provide more detail about microplastics, their origin and use, their geographic distribution, and the effects they may have on human health and environmental health.

 Course Objectives

By the end of this course, learners will be able to:
  • State the molecular structural feature common to plastics of different types.
  • Explain why most plastics remain persistent in the environment for long periods of time.
  • Define microplastics.
  • Explain how microplastics are generated in the environment.
  • List common sources of microplastics that enter our waterways.
  • Explain the possible and likely health effects of microplastics on human health.
  • Explain the possible and likely health effects of microplastics on aquatic life List alternatives to the use of plastics as a consumer.
See course outline below for additional information.

This course includes:

  • Video recording
  • Downloadable audio
  • Speaker handout(s)
  • 1 Quiz
  • 1 Evaluation
  • Certificate of Completion

Course Faculty

Dan Handley, MS, PhD

Bio

Dr. Handley serves as Professor, Director of the Clinical and Translational Genome Research Institute (CTGRI), and Director of the Master of Science in Human Genetics and Genomics degree program at the Southern California University of Health Sciences. He also serves on the Board of Directors of Predictive Oncology, Inc. (NASDAQ: POAI). Previously, he held a courtesy faculty appointment in the Department of Biological Sciences at Florida Gulf Coast University. He has served as Chief Scientific Officer for Life-SEQ, LLC., Chief Scientific Officer for Advanced Healthcare Technology Solutions, Inc., as a senior researcher at the Procter & Gamble Co., a senior administrator and laboratory manager at the David Geffen School of Medicine at UCLA, and as a founding technology innovator for the National Genetics Institute. He holds a B.A. in Biophysics from Johns Hopkins University, an M.S. in Logic and Computation from Carnegie Mellon University, a Ph.D. in Human Genetics from the University of Pittsburgh, and did his post-doctoral training at Magee-Women's Research Institute in advanced genomic technologies applied to fetal and maternal health

Disclosure

  • Predictive Oncology, Inc.


All disclosures were mitigated prior to the activity.

Accreditation and CME

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of California, Irvine School of Medicine and the Academy of Integrative Health & Medicine. The University of California, Irvine School of Medicine is accredited by the ACCME to provide continuing medical education for physicians. 

This activity is in compliance with California Assembly Bill 1195, which requires continuing medical education activities with patient care components to include curriculum in the subjects of cultural and linguistic competency. For specific information regarding Bill 1195 and cultural and linguistic competency, please visit the
CME website.

*CME/CEU Credits

The University of California, Irvine School of Medicine designates this enduring materials for a maximum of .75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

All other healthcare professionals
 completing this activity will be issued a certificate of participation. To successfully earn credit, participants must review the content, complete a quiz with a score of 75% or higher, and submit an evaluation. This course is CME-eligible ending on December 31, 2022. After this date, you will continue to have access to your purchased content, however you will no longer be able to claim CME credits for your participation in the course.
The views and opinions expressed in this activity are those of the faculty and do not necessarily reflect the views of the University of California, Irvine School of Medicine and/or the Academy of Integrative Health & Medicine.

Enroll Now!

This course is self-paced with no set beginning or end date. You may complete this course on your own schedule and pace. Enrolling in and purchasing this course grants you access to its contents in perpetuity. All required course activities must be completed to earn any eligible continuing education credit(s) and obtain a certificate of completion for this course.